LMI and PharmaLogic to Supply Neuraceq in Denver
Neuraceq is an FDA-approved imaging agent for the detection of beta-amyloid plaques in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline.
PharmaLogic | 21/08/2024 | By Aishwarya
Nusano and PharmaLogic to Offer Current and Emerging Radiopharmaceuticals
Nusano Inc. has inked a supply agreement with PharmaLogic to provide a more efficient and reliable supply of critical radioisotopes.
PharmaLogic | 11/07/2024 | By Aishwarya
PharmaLogic Opens New Radiopharmaceutical Production Facility in Cincinnati
PharmaLogic Holdings Corp. has opened its new radiopharmaceutical production and research facility in Cincinnati, Ohio.
PharmaLogic | 23/04/2024 | By Aishwarya | 316
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy